देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
chlorpromazine hydrochloride, Quantity: 5 mg/mL
Clinect Pty Ltd
Chlorpromazine hydrochloride
Oral Liquid
Excipient Ingredients: sucrose; caramel; Peppermint Oil; Spearmint oil; polysorbate 20; purified water; citric acid; sodium citrate dihydrate; ascorbic acid; sodium sulfite; sodium metabisulfite; sodium benzoate; Flavour
Oral
100ml bottle, 500ml bottle
(S4) Prescription Only Medicine
1. Treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. Long-term treatment of schizophrenia. 3. Short-term treatment of agitation and severe depression. 4. Severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. Use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. In the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. Control of intractable hiccough.
Visual Identification: A clear bright golden brown syrupy liquid; Container Type: Bottle; Container Material: Glass Type III Coloured; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2005-05-02
LARGACTIL ® _chlorpromazine hydrochloride_ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Largactil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor or pharmacist has weighed the risks of you taking Largactil against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THIS MEDICINE. You may need to read it again. WHAT LARGACTIL IS USED FOR The active ingredient of Largactil is chlorpromazine hydrochloride, one of a group of medicines called phenothiazines. Largactil is used to treat a number of conditions and may be used either for a short time or for a long time. Largactil is used to treat various problems such as severe depression or behavioural disturbances. Largactil can also be used to treat nausea, vomiting, severe pain and unstoppable hiccups. Your doctor may have prescribed Largactil for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY LARGACTIL HAS BEEN PRESCRIBED FOR YOU. Largactil is available only with a doctor's prescription. BEFORE YOU TAKE IT _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE LARGACTIL IF YOU HAVE AN ALLERGY OR ANY OTHER REACTION TO LARGACTIL OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. DO NOT TAKE LARGACTIL IF YOU HAVE TAKEN ANY OTHER 'PHENOTHIAZINE' MEDICINE BEFORE, WHICH CAUSED YOUR FACE, LIPS, TONGUE, THROAT, HANDS OR FEET TO SWELL UP, OR MADE IT HARD FOR YOU TO BREATHE. If you have had an allergic reaction to a phenothiazine before, you may be allergic to Largactil. DO NOT TAKE LARGACTIL IF YOU HAVE ANY OF THE FOLLOWING: • circulatory, blood or bone marrow problems • high blood pressure • phaeochromocytoma - a rare tumour of the adrenal gland which sits near the kidneys • liver problems • CNS depression, e.g. coma or drug intoxication DO NOT TAKE LARGACTIL AFTER पूरा दस्तावेज़ पढ़ें
largactil-ccdsv4-piv13-17dec19 1 AUSTRALIAN PRODUCT INFORMATION – LARGACTIL (CHLORPROMAZINE HYDROCHLORIDE) 1 NAME OF THE MEDICINE Chlorpromazine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Tablets: Each tablet contains 10 mg, 25 mg or 100 mg of chlorpromazine hydrochloride Syrup: Each 1 mL of syrup contains 5 mg of chlorpromazine hydrochloride Injection: The injection solution contains 50 mg/2 mL of chlorpromazine hydrochloride Excipients with known effect: Tablets: Lactose Monohydrate Syrup: Sucrose, sodium sulfite, sodium metabisulfite, sodium benzoate Injection: Sodium sulfite, sodium metabisulfite For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM Tablets, Syrup, Injection Solution TABLETS 10 mg: white to off-white, circular biconvex, film-coated tablets one face impressed LG10 with the reverse side plain film coated tablet 25 mg: white to off-white, circular biconvex, film-coated tablets one face impressed LG25 with the reverse side plain film coated 100 mg: white to off-white, circular biconvex, film-coated tablets one face impressed LG100 with the reverse side plain film coated SYRUP The syrup is a clear bright, golden brown, syrupy liquid INJECTION The injection solution is a clear, bright, very pale yellow liquid. largactil-ccdsv4-piv13-17dec19 2 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of acute functional psychosis (e.g. schizophrenia, mania or psychotic depression). Long-term treatment of schizophrenia. Short-term treatment of agitation and severe depression. Severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. Use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. In the management of terminal illness t पूरा दस्तावेज़ पढ़ें